Literature DB >> 3181279

Plasma concentrations of noradrenaline and 3,4-dihydroxyphenylethyleneglycol under conditions of enhanced sympathetic activity.

J Ludwig1, T Gerhardt, T Halbrügge, J Walter, K H Graefe.   

Abstract

Antecubital venous blood was sampled at rest and during orthostasis or supine bicycle exercise. The plasma was analyzed for noradrenaline and 3,4-dihydroxyphenylethyleneglycol (DOPEG) by HPLC. Orthostasis resulted in increases in plasma concentrations of both noradrenaline and DOPEG. The magnitude of changes in both was dependent on the degree of orthostasis. In conditions of supine rest, sitting, and standing the plot of the geometric mean values of plasma DOPEG (ordinate) against those of plasma noradrenaline was linear, had a slope of about unity, and intersected the ordinate at a finite value of plasma DOPEG. After administration of desipramine (to block uptake), plasma concentrations of DOPEG fell both at rest and during orthostasis. Moreover, desipramine abolished the plasma DOPEG response to orthostasis without affecting the plasma noradrenaline response. Hence, changes in plasma DOPEG brought about by changes in sympathetic tone are presynaptic in origin. The plasma concentration of DOPEG observed in the presence of desipramine was virtually identical with the ordinate intercept of the regression line relating plasma DOPEG to plasma noradrenaline in the absence of desipramine. This pool of plasma DOPEG (which amounted to about 75% of that observed at supine rest in the absence of desipramine) probably stems from intraneuronal noradrenaline leaking out of the storage vesicles of peripheral sympathetic neurones and may in part also be derived from the central nervous system. Supine bicycle exercise failed to increase plasma DOPEG. This may be due to the separation of the sampling site from the site of noradrenaline release (i.e. the exercising limbs) by organs involved in DOPEG extraction.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3181279     DOI: 10.1007/bf00558263

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

2.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 3.  The rate constants for the efflux of metabolites of catecholamines and phenethylamines.

Authors:  U Trendelenburg; H Bönisch; K H Graefe; M Henseling
Journal:  Pharmacol Rev       Date:  1979-09       Impact factor: 25.468

Review 4.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

5.  Simultaneous assay of 3,4-dihydroxyphenylethylene glycol and norepinephrine in human plasma by high-performance liquid chromatography with electrochemical detection.

Authors:  L G Howes; S Miller; J L Reid
Journal:  J Chromatogr       Date:  1985-03-22

6.  Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.

Authors:  D S Robinson; G A Johnson; A Nies; J Corcella; T B Cooper; D Albright; D Howard
Journal:  J Clin Psychopharmacol       Date:  1983-10       Impact factor: 3.153

7.  A comparative study of the uptake and metabolism of noradrenaline and adrenaline by the isolated saphenous vein of the dog.

Authors:  M Q Paiva; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

8.  Pulmonary extraction of circulating noradrenaline in man.

Authors:  J H Henriksen; N J Christensen; H Ring-Larsen
Journal:  Eur J Clin Invest       Date:  1986-10       Impact factor: 4.686

9.  Effect of norepinephrine uptake blockers on norepinephrine kinetics.

Authors:  M Esler; G Jackman; P Leonard; H Skews; A Bobik; P Korner
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

10.  Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.

Authors:  T Halbrügge; T Gerhardt; J Ludwig; E Heidbreder; K H Graefe
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

View more
  9 in total

1.  Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit.

Authors:  T Halbrügge; B Friedgen; J Ludwig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

2.  Plasma 3,4-dihydroxyphenylglycol as a tool to assess the role of neuronal uptake in the anaesthetized rabbit.

Authors:  T Halbrügge; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

3.  Desipramine inhibits sympathetic nerve activity in the rabbit.

Authors:  B Sazbo; A Schultheiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

4.  Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline.

Authors:  J Ludwig; T Halbrügge; G Vey; J Walter; K H Graefe
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

5.  Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit.

Authors:  O S Medvedev; M D Esler; J A Angus; H S Cox; G Eisenhofer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

6.  Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

Authors:  T Halbrügge; A L Ungell; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

7.  Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.

Authors:  G Eisenhofer; H S Cox; M D Esler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

Review 8.  The biochemical assessment of sympathoadrenal activity in man.

Authors:  N J Christensen
Journal:  Clin Auton Res       Date:  1991-06       Impact factor: 4.435

9.  Estimation of noradrenaline concentrations in the axoplasm of noradrenergic neurones in man.

Authors:  J Ludwig; T Halbrügge; M Gerlich; K H Graefe
Journal:  Clin Auton Res       Date:  1992-06       Impact factor: 4.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.